| 0 (0%) | 09-27 11:13 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 77.16 | 1-year : | 80.14 |
| Resists | First : | 66.06 | Second : | 68.62 |
| Pivot price | 63.85  |
|||
| Supports | First : | 61.93 | Second : | 51.52 |
| MAs | MA(5) : | 63.1 |
MA(20) : | 64.55 |
| MA(100) : | 75.54 |
MA(250) : | 78.26 |
|
| MACD | MACD : | -1.5 |
Signal : | -1.6 |
| %K %D | K(14,3) : | 21.8 |
D(3) : | 21.3 |
| RSI | RSI(14): 37 |
|||
| 52-week | High : | 90.04 | Low : | 61.93 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ PBH ] has closed above bottom band by 29.0%. Bollinger Bands are 43.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 63.21 - 63.52 | 63.52 - 63.78 |
| Low: | 61.45 - 61.81 | 61.81 - 62.12 |
| Close: | 62.44 - 62.99 | 62.99 - 63.47 |
Fri, 26 Sep 2025
(PBH.DB.G) Advanced Trading Insights - news.stocktradersdaily.com
Fri, 26 Sep 2025
Objective long/short (PBH.DB.I) Report (PBH.DB.I:CA) - news.stocktradersdaily.com
Tue, 23 Sep 2025
Read This Before Judging Premium Brands Holdings Corporation's (TSE:PBH) ROE - simplywall.st
Thu, 18 Sep 2025
Prestige Consumer Healthcare Inc. (PBH) Moves to Stabilize Eye Care Amid 2025 Headwinds - Yahoo Finance
Mon, 15 Sep 2025
Prestige Consumer Healthcare Becomes Oversold (PBH) - Nasdaq
Mon, 15 Sep 2025
Guggenheim raises Amylyx Pharmaceuticals stock price target on PBH potential - Investing.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 49 (M) |
| Shares Float | 49 (M) |
| Held by Insiders | 1.2 (%) |
| Held by Institutions | 107.8 (%) |
| Shares Short | 1,420 (K) |
| Shares Short P.Month | 1,300 (K) |
| EPS | 4.26 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 37.7 |
| Profit Margin | 19 % |
| Operating Margin | 28.7 % |
| Return on Assets (ttm) | 6.4 % |
| Return on Equity (ttm) | 12 % |
| Qtrly Rev. Growth | -6.6 % |
| Gross Profit (p.s.) | 12.95 |
| Sales Per Share | 22.75 |
| EBITDA (p.s.) | 7.69 |
| Qtrly Earnings Growth | -3.1 % |
| Operating Cash Flow | 276 (M) |
| Levered Free Cash Flow | 210 (M) |
| PE Ratio | 14.78 |
| PEG Ratio | 0 |
| Price to Book value | 1.66 |
| Price to Sales | 2.76 |
| Price to Cash Flow | 11.23 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|